ArticleClinical rheumatology2017

Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.

Sara Monti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.